The peculiar features, diversity and impact of citrulline-reactive autoantibodies

Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).

Article  PubMed  Google Scholar 

Rose, H. M., Ragan, C., Pearce, E. & Lipman, M. O. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 68, 1–6 (1948).

Article  CAS  PubMed  Google Scholar 

Nienhuis, R. L. F., Mandema, E. & Smids, C. New serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann. Rheum. Dis. 23, 302 (1964).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Young, B. J., Mallya, R. K., Leslie, R. D., Clark, C. J. & Hamblin, T. J. Anti-keratin antibodies in rheumatoid arthritis. Br. Med. J. 2, 97 (1979).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sebbag, M. et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Investig. 95, 2672–2679 (1995).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273–281 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vossenaar, E. R. et al. Multiplex analysis of antinuclear antibodies by flow cytometry using FIDIS. Arthritis Res. Ther. 6, 8 (2004).

Google Scholar 

Masson-Bessière, C. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J. Immunol. 166, 4177–4184 (2001).

Article  PubMed  Google Scholar 

Burkhardt, H. et al. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur. J. Immunol. 35, 1643–1652 (2005).

Article  CAS  PubMed  Google Scholar 

Kinloch, A. et al. Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7, R1421 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pratesi, F. et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann. Rheum. Dis. 73, 1414 (2014).

Article  CAS  PubMed  Google Scholar 

Hefton, A. et al. Autoantibodies against citrullinated serum albumin in patients with rheumatoid arthritis. J. Transl. Autoimmun. 2, 100023 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Schwenzer, A. et al. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. Ann. Rheum. Dis. 75, 1876 (2016).

Article  CAS  PubMed  Google Scholar 

Rakieh, C. et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann. Rheum. Dis. 74, 1659 (2015).

Article  CAS  PubMed  Google Scholar 

Studenic, P. et al. Prospective studies on the risk of rheumatoid arthritis: the European risk RA registry. Front. Med. 9, 824501 (2022).

Article  Google Scholar 

Stadt et al. Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns. Rheumatology 52, 631–635 (2013).

Article  PubMed  Google Scholar 

Titcombe, P. J. et al. Pathogenic citrulline‐multispecific B cell receptor clades in rheumatoid arthritis. Arthritis Rheumatol. 70, 1933–1945 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steen, J. et al. Recognition of amino acid motifs, rather than specific proteins, by human plasma cell–derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid arthritis. Arthritis Rheumatol. 71, 196–209 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kongpachith, S. et al. Affinity maturation of the anti–citrullinated protein antibody paratope drives epitope spreading and polyreactivity in rheumatoid arthritis. Arthritis Rheumatol. 71, 507–517 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elliott, S. E. et al. B cells in rheumatoid arthritis synovial tissues encode focused antibody repertoires that include antibodies that stimulate macrophage TNF-α production. Clin. Immunol. 212, 108360 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hensvold, A. et al. The human bone marrow plasma cell compartment in rheumatoid arthritis — clonal relationships and anti-citrulline autoantibody producing cells. J. Autoimmun. 136, 103022 (2023).

Article  CAS  PubMed  Google Scholar 

Joshua, V. et al. Rheumatoid arthritis-specific autoimmunity in the lung before and at the onset of disease. Arthritis Rheumatol. 75, 1910–1922 (2023).

Article  CAS  PubMed  Google Scholar 

Klareskog, L. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA–DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54, 38–46 (2006).

Article  CAS  PubMed  Google Scholar 

Kuhn, K. A. et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Investig. 116, 961–973 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petkova, S. B. et al. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcγRIIB. J. Exp. Med. 203, 275–280 (2006).

Article  PubMed  PubMed Central  Google Scholar 

Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Investig. 122, 1791–1802 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra40 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Krishnamurthy, A. et al. Combination of two monoclonal anti–citrullinated protein antibodies induced tenosynovitis, pain, and bone loss in mice in a peptidyl arginine deiminase‐4-dependent manner. Arthritis Rheumatol. 75, 164–170 (2023).

Article  CAS  PubMed  Google Scholar 

Chirivi, R. G. S. et al. Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol. Immunol. 18, 1528–1544 (2021).

Article  CAS  PubMed  Google Scholar 

Raposo, B. et al. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann. Rheum. Dis. 82, 724–726 (2023).

Article  CAS  PubMed  Google Scholar 

He, Y. et al. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. Nat. Commun. 14, 691 (2023).

留言 (0)

沒有登入
gif